Breaking News Instant updates and real-time market news.

ZYME

Zymeworks

$6.68

0.1956 (3.02%)

16:15
08/08/17
08/08
16:15
08/08/17
16:15

Zymeworks reports Q2 net loss $11M

Reports Q2 revenue $1.3M. As of June 30, Zymeworks had $62.5M in cash and cash equivalents and short-term investments. The company said, "During the second quarter, in addition to the completion of our initial public offering, we made significant progress on our clinical and partnered programs. We presented detailed dose escalation data at ASCO demonstrating safety and anti-tumor activity for ZW25. We also announced progress in our collaboration with Eli Lilly as they nominated two drug candidates for late-stage preclinical development. This highlights the continual advancement of therapeutic programs being developed by our Pharma partners towards the clinic."

  • 08

    Aug

  • 09

    Aug

ZYME Zymeworks
$6.68

0.1956 (3.02%)

05/23/17
WELS
05/23/17
INITIATION
WELS
Outperform
Zymeworks initiated with an Outperform at Wells Fargo
Wells Fargo started coverage of Zymeworks (ZYME) with a $20 price target and an Outperform rating. The firm says that the company has "a potential best-in-class bispecific antibody platform, a deep pipeline focused on novel cancer therapeutics , an attractive (breast cancer treatment) with early validation in a $10B category and a high profile collaboration with oncology leader Celgene (CELG)." Wells notes that the company's breast cancer treatment,, ZW25, has "shown early evidence of tumor response." Wells views the collaboration with Celgene "as particularly validating" for Zymeworks. It keeps an Outperform rating on Zymeworks.
05/23/17
05/23/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cloudera (CLDR) was initiated with an Overweight at JPMorgan, a Buy at Stifel and Deutsche Bank, a Market Perform at JMP Securities, an Equal Weight at Morgan Stanley, and a Neutral at Citi. 2. Emerald Expositions Events (EEX) was initiated with an Outperform at RBC Capital, an Overweight at Barclays, a Buy at BofA/Merrill and Deutsche Bank, as well as a Neutral at Goldman Sachs, Credit Suisse, and Baird. 3. Zymeworks (ZYME) was initiated with an Outperform at Wells Fargo, an Overweight at Barclays, and a Buy at Canaccord. 4. Carvana (CVNA) was initiated with an Outperform at William Blair, JMP Securities, BMO Capital, Wells Fargo, and Baird, as well as a Buy at BofA/Merrill and Citi. 5. J.B. Hunt (JBHT) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/17
SBSH
05/24/17
INITIATION
Target $18
SBSH
Buy
Zymeworks initiated with a Buy at Citi
Citi analyst Yigal Nochomovitz started Zymeworks with a Buy rating and $18 price target. The analyst believes the company's platform and technology could open the door to a bigger piece of the breast cancer market.
05/24/17
05/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Shake Shack (SHAK) initiated with an Overweight at Piper Jaffray. 2. Zymeworks (ZYME) initiated with a Buy at Citi. 3. Murphy Oil (MUR) initiated with a Buy at KLR Group. 4. Atlas Financial (AFH) initiated with an Outperform at JMP Securities. 5. Emerald Expositions Events (EEX) initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CGC

Canopy Growth

$47.83

1.75 (3.80%)

11:05
03/20/19
03/20
11:05
03/20/19
11:05
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.51

-0.195 (-2.24%)

11:03
03/20/19
03/20
11:03
03/20/19
11:03
Hot Stocks
Ford to invest over $850M to expand EV production capacity at Michigan plant »

Ford announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CMTL

Comtech

$21.65

-0.33 (-1.50%)

11:01
03/20/19
03/20
11:01
03/20/19
11:01
Hot Stocks
Comtech receives $2.2M contract for Midia gas development project in Romania »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

F

Ford

$8.50

-0.205 (-2.36%)

11:01
03/20/19
03/20
11:01
03/20/19
11:01
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford to invest more than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

T

AT&T

$30.47

-0.23 (-0.75%)

10:55
03/20/19
03/20
10:55
03/20/19
10:55
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

Chairman & CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 20

    May

GOOG

Alphabet

$1,206.02

6.31 (0.53%)

, GOOGL

Alphabet Class A

$1,209.61

6.48 (0.54%)

10:53
03/20/19
03/20
10:53
03/20/19
10:53
Periodicals
Supreme Court orders new look at $8.5M Google settlement, Bloomberg says »

The U.S. Supreme Court…

GOOG

Alphabet

$1,206.02

6.31 (0.53%)

GOOGL

Alphabet Class A

$1,209.61

6.48 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

BFRA

Biofrontera

$11.88

(0.00%)

10:52
03/20/19
03/20
10:52
03/20/19
10:52
Hot Stocks
Biofrontera says Ameluz Phase 3 study met primary regulatory endpoint »

Biofrontera announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$56.86

-0.1 (-0.18%)

10:50
03/20/19
03/20
10:50
03/20/19
10:50
Options
Aggressive call buyers in Qualcomm »

Aggressive call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

CYTK

Cytokinetics

$9.80

1.24 (14.49%)

10:47
03/20/19
03/20
10:47
03/20/19
10:47
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIGR

UP Fintech

$0.00

(0.00%)

10:43
03/20/19
03/20
10:43
03/20/19
10:43
Syndicate
Breaking Syndicate news story on UP Fintech »

UP Fintech opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MNST

Monster Beverage

$56.91

-0.96 (-1.66%)

, FDX

FedEx

$171.66

-9.84 (-5.42%)

10:42
03/20/19
03/20
10:42
03/20/19
10:42
On The Fly
Monster, FedEx, Teradata downgrades among today's top analyst calls »

Check out today's top…

MNST

Monster Beverage

$56.91

-0.96 (-1.66%)

FDX

FedEx

$171.66

-9.84 (-5.42%)

NVRO

Nevro

$60.20

15.44 (34.50%)

TDC

Teradata

$45.50

-2.83 (-5.86%)

LYFT

Lyft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 01

    Apr

  • 02

    Apr

  • 30

    Apr

  • 25

    Jun

  • 29

    Mar

NVRO

Nevro

$60.27

15.51 (34.65%)

10:40
03/20/19
03/20
10:40
03/20/19
10:40
On The Fly
Nevro jumps over 30% after appointing new 'turnaround CEO' »

Shares of Nevro (NVRO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

VNQ

Vanguard REIT Index Fund

$84.62

-0.46 (-0.54%)

10:40
03/20/19
03/20
10:40
03/20/19
10:40
Options
Size put spread in Vanguard Real Estate ETF rolls a defensive position »

Size put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
03/20/19
03/20
10:40
03/20/19
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

UBER

Uber

$0.00

(0.00%)

10:39
03/20/19
03/20
10:39
03/20/19
10:39
Hot Stocks
Uber Freight launching in Europe »

After launching in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIGR

UP Fintech

$0.00

(0.00%)

10:33
03/20/19
03/20
10:33
03/20/19
10:33
Syndicate
Breaking Syndicate news story on UP Fintech »

UP Fintech indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

10:32
03/20/19
03/20
10:32
03/20/19
10:32
General news
Crude inventories for week of March 15 »

Crude oil inventories…

CAG

Conagra Brands

$22.68

-0.13 (-0.57%)

10:30
03/20/19
03/20
10:30
03/20/19
10:30
Options
Impressive call buy in Conagra longer-term contracts ahead of earnings »

Impressive call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

TIGR

UP Fintech

$0.00

(0.00%)

10:28
03/20/19
03/20
10:28
03/20/19
10:28
Syndicate
Breaking Syndicate news story on UP Fintech »

UP Fintech indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

F

Ford

$8.52

-0.19 (-2.18%)

10:25
03/20/19
03/20
10:25
03/20/19
10:25
Options
Ford call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

10:25
03/20/19
03/20
10:25
03/20/19
10:25
General news
U.S. equities rolled over into the red »

U.S. equities rolled over…

10:25
03/20/19
03/20
10:25
03/20/19
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

AIG

AIG

$43.84

-0.04 (-0.09%)

10:22
03/20/19
03/20
10:22
03/20/19
10:22
Hot Stocks
VALIC rebrands to AIG Retirement Services »

VALIC will now be known…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

TIGR

UP Fintech

$0.00

(0.00%)

10:20
03/20/19
03/20
10:20
03/20/19
10:20
Syndicate
UP Fintech indicated to open at $8.60, IPO priced at $8.00 »

UP Fintech (TIGR) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

LYFT

Lyft

$0.00

(0.00%)

, UBER

Uber

$0.00

(0.00%)

10:18
03/20/19
03/20
10:18
03/20/19
10:18
On The Fly
Lyft receives first Buy rating ahead of IPO »

Ride-hailing firm Lyft…

LYFT

Lyft

$0.00

(0.00%)

UBER

Uber

$0.00

(0.00%)

PIN

Pinterest

$25.55

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.